Mechanism: Aged gut permeability allows microbial DNA to activate cGAS-STING in enteric neurons, initiating a p16INK4a+ senescent state and SASP factor release that mirrors in the NTS via the vagus nerve. Readout: Readout: Interventions like polymyxin B reduce gut-brain SASP gradients and improve system health from 'CRITICAL (95%)' to 'OPTIMAL (15%)' on the inflammaging meter.
Hypothesis
Age‑related increases in gut permeability allow microbial DNA to activate the cGAS‑STING pathway in enteric neurons, triggering a localized p16^INK4a^+ senescent niche whose SASP factors diffuse along the vagus nerve and induce a mirrored senescent microenvironment in the nucleus of the solitary tract (NTS). This bidirectional senescence gradient propagates inflammaging from the microbiome to the brain.
Mechanistic Rationale
- Microbial translocation → cGAS‑STING activation → IFN‑β‑driven p16^INK4a^ expression in myenteric plexus neurons [3].
- Senescent enteric neurons secrete IL‑6, CCL2, and ATP, which travel via vagal afferents to the NTS [1].
- In the NTS, these signals promote astrocyte and microglial senescence through NAD+ depletion and NF‑κB signaling, creating a SASP gradient that mirrors the gut pattern [2], 5].
- Heterochronic parabiosis data show that circulating factors can reset senescent cell loads in both gut and brain, supporting a systemic coupling mechanism [4].
- The ENS possesses region‑specific transcriptomic identities that remain unmapped in aging contexts, offering a spatial scaffold for senescence niches [6].
Testable Predictions
- In aged mice, p16^INK4a^+ clusters will be enriched in the myenteric plexus and the NTS, with SASP factor mRNA (Il6, Ccl2, Cxcl10) showing a distance‑dependent decay from each cluster.
- The slope of SASP decay will be statistically similar between gut and brain tissues when normalized to tissue thickness.
- Reducing microbial translocation (e.g., with oral polymyxin B or a tight‑junction enhancer) will diminish p16^INK4a^+ density and SASP gradients in both ENS and NTS.
- Chemogenetic inhibition of vagal afferents will uncouple the gut‑brain SASP similarity, leaving intestinal senescence intact while blunting NTS senescence.
Experimental Design
- Use dual‑tissue MERFISH (or high‑plex Visium) on young (3 mo) and aged (24 mo) mice, targeting senescence markers (p16^INK4a^, p21^Cip1^), SASP cytokines, and neuronal/glial identity genes.
- Quantify nearest‑neighbor distances from p16^INK4a^+ cells to SASP transcripts; fit exponential decay models to derive gradient length‑constants.
- Parallel cohorts receive: (a) broad‑spectrum antibiotics, (b) vagotomy, (c) sham treatment. Harvest tissues after 4 weeks.
- Validate microbial translocation by qPCR for bacterial 16S rRNA in portal blood and liver.
Potential Outcomes and Falsifiability
- Supported: Significant correlation (r > 0.6) between gut and brain SASP length‑constants in aged controls; attenuation of both gradients by barrier‑strengthening or vagal blockade.
- Refuted: No spatial correlation between gut and brain SASP gradients, or manipulation of microbial translocation/vagal signaling fails to alter NTS senescence despite changes in the ENS.
This framework converts the "messy" bidirectional dialogue into a quantifiable, spatially resolved test of whether the microbiome’s biological age sets the tempo of brain aging through senescence signaling.
Comments
Sign in to comment.